What side effects are associated with this type of intervention?

Cognitive Behavioral Therapy (CBT) and similar cognitive and behavioral techniques used to treat functional memory symptoms after concussion are generally well-tolerated with minimal side effects. Common side effects may include temporary increases in anxiety or emotional discomfort as patients confront challenging thoughts and feelings. Some individuals might experience fatigue or stress due to the mental effort required during therapy sessions. Overall, these side effects are typically mild and transient, making CBT a safe and effective option for managing post-concussion symptoms.

What prior FDA approvals exist?

There are no specific FDA-approved drugs mentioned in the provided context for the treatment of concussion, particularly those targeting memory symptoms through Cognitive Behavioral Therapy (CBT). The context does discuss a study evaluating the feasibility of a novel CBT-based intervention for improving functional memory symptoms after concussion, but it does not mention any FDA-approved treatments or related drugs for this purpose. Generally, concussion management focuses on rest, symptom management, and gradual return to activities, with CBT being explored as a potential therapeutic approach for cognitive symptoms.

What other types of research exist?

One promising alternative to Cognitive Behavioural Therapy (CBT) for improving memory symptoms in concussion patients is cognitive rehabilitation. This approach involves structured therapeutic activities designed to improve cognitive functions such as memory, attention, and problem-solving skills. Another potential alternative is the use of mindfulness-based cognitive therapy (MBCT), which combines traditional cognitive therapy techniques with mindfulness strategies to enhance cognitive function and emotional regulation.

← Back to Search

Cognitive Rehabilitation for Concussion

N/A

Waitlist Available

Led By Noah Silverberg, PhD

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-59 years old

Age 18-65 years old

Must not have

Unstable/serious medical condition (e.g., cancer, multiple sclerosis, etc.),

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new therapy to help people with long-term memory problems after a concussion. It focuses on changing negative thoughts about memory. The study targets those who had a concussion within the past few months to a couple of years and still have memory issues. The goal is to see if this therapy is practical and effective.

Who is the study for?

This trial is for adults aged 18-65 who had a concussion 6-24 months ago, meet criteria for Functional Cognitive Disorder, speak English fluently, and have regular internet access. It's not for those with serious conditions like cancer or MS, MRI contraindications, failed validity tests, severe mental illness requiring recent hospitalization, substance abuse disorders, or on memory-impairing meds.

What is being tested?

The study is testing a new cognitive behavioural therapy (CBT) aimed at improving memory after a concussion. Participants will be randomly assigned to either this CBT or an alternative cognitive rehabilitation program to compare effectiveness. The focus is on how feasible the treatment is based on recruitment success and participant adherence.

What are the potential side effects?

Since the interventions are non-medical therapies (CBT and cognitive rehabilitation), they typically do not have side effects like drugs do. However, participants may experience emotional discomfort discussing their experiences during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 59 years old.

Select...

I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have any serious or unstable medical conditions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Memory concern

Patient adherence

Recruitment

+3 more

Secondary study objectives

Avoidance

Catastrophization

Patient Global Impression of Change

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Cognitive Behavioural Therapy (CBT)Experimental Treatment1 Intervention

11 weekly sessions of cognitive behavioural therapy (CBT) delivered over videoconference

Group II: Cognitive RehabilitationActive Control1 Intervention

11 weekly sessions of traditional cognitive rehabilitation delivered over videoconference

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Behavioural Therapy (CBT)

2017

N/A

~970

0 / 3Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Cognitive Behavioral Therapy (CBT) is a common treatment for concussion that focuses on improving functional memory symptoms through cognitive and behavioral techniques. The mechanism of action involves helping patients develop strategies to manage and compensate for memory deficits, enhancing their cognitive control, and reducing the psychological impact of memory problems. This is crucial for concussion patients as it not only aids in the recovery of cognitive functions but also helps in managing associated emotional and psychological stress, thereby improving overall quality of life.